Literature DB >> 22918154

Prevalence of proteinuria and elevated serum cystatin C among HIV-Infected Adolescents in the Reaching for Excellence in Adolescent Care and Health (REACH) study.

Kristal J Aaron1, Mirjam-Colette Kempf, Robert H Christenson, Craig M Wilson, Paul Muntner, Sadeep Shrestha.   

Abstract

OBJECTIVE: In the United States, kidney dysfunction is prevalent in almost 30% of HIV-infected patients and is an independent predictor of mortality. Proteinuria and elevated serum cystatin C (eCysC) are used as markers of kidney disease in the general population; however, the prevalence of these markers in HIV-infected adolescents is largely unknown.
METHODS: This study includes 304 HIV-infected adolescents from the Reaching for Excellence in Adolescent Care and Health (REACH) cohort, an observational study of adolescents recruited from 13 US cities. Clinical and demographic characteristics of participants were evaluated as correlates of proteinuria, a urine protein to creatinine ratio of ≥200 mg/g. Select univariate predictors were assessed to determine the association with urinary protein excretion and serum cystatin C in multivariable linear regression models and proteinuria and eCysC (eCysC ≥ 75th percentile) in multivariable logistic regression models.
RESULTS: Overall, 19.1% of the participants had proteinuria, whereas 23.7% had an eCysC. Low CD4 T-lymphocyte counts (<200 cells/mm) were significantly associated with a greater urine protein to creatinine ratio in linear models and with proteinuria in logistic regression models. CD4 T-lymphocyte counts <500 cells/mm were significantly associated with a greater serum cystatin C concentration in linear models and with eCysC in logistic regression models.
CONCLUSIONS: Proteinuria among HIV-infected adolescents in the REACH cohort was approximately 2-fold greater than healthy US adolescents. Both proteinuria and eCysC are associated with CD4 T-lymphocyte counts. Further studies investigating early markers of kidney disease and the association with immune status and inflammation in HIV-infected adolescents are needed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22918154      PMCID: PMC3494783          DOI: 10.1097/QAI.0b013e31826d7421

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  63 in total

1.  Body fat distribution in perinatally HIV-infected and HIV-exposed but uninfected children in the era of highly active antiretroviral therapy: outcomes from the Pediatric HIV/AIDS Cohort Study.

Authors:  Denise L Jacobson; Kunjal Patel; George K Siberry; Russell B Van Dyke; Linda A DiMeglio; Mitchell E Geffner; Janet S Chen; Elizabeth J McFarland; William Borkowsky; Margarita Silio; Roger A Fielding; Suzanne Siminski; Tracie L Miller
Journal:  Am J Clin Nutr       Date:  2011-11-02       Impact factor: 7.045

2.  Renal dysfunction among HIV-infected patients starting antiretroviral therapy.

Authors:  Leonard Msango; Jennifer A Downs; Samuel E Kalluvya; Benson R Kidenya; Rodrick Kabangila; Warren D Johnson; Daniel W Fitzgerald; Robert N Peck
Journal:  AIDS       Date:  2011-07-17       Impact factor: 4.177

Review 3.  Early change in proteinuria as a surrogate outcome in kidney disease progression: a systematic review of previous analyses and creation of a patient-level pooled dataset.

Authors:  Nicholas Stoycheff; Kruti Pandya; Aghogho Okparavero; Abigail Schiff; Andrew S Levey; Tom Greene; Lesley A Stevens
Journal:  Nephrol Dial Transplant       Date:  2010-09-03       Impact factor: 5.992

4.  Does HAART improve renal function? An association between serum cystatin C concentration, HIV viral load and HAART duration.

Authors:  Jerzy Jaroszewicz; Alicja Wiercinska-Drapalo; Tadeusz W Lapinski; Danuta Prokopowicz; Magdalena Rogalska; Anna Parfieniuk
Journal:  Antivir Ther       Date:  2006

5.  Estimating glomerular filtration rate from serum creatinine and cystatin C.

Authors:  Lesley A Inker; Christopher H Schmid; Hocine Tighiouart; John H Eckfeldt; Harold I Feldman; Tom Greene; John W Kusek; Jane Manzi; Frederick Van Lente; Yaping Lucy Zhang; Josef Coresh; Andrew S Levey
Journal:  N Engl J Med       Date:  2012-07-05       Impact factor: 91.245

6.  Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate.

Authors:  Josef Coresh; Brad C Astor; Geraldine McQuillan; John Kusek; Tom Greene; Frederick Van Lente; Andrew S Levey
Journal:  Am J Kidney Dis       Date:  2002-05       Impact factor: 8.860

7.  Renal disease in HIV-seropositive patients in Nigeria: an assessment of prevalence, clinical features and risk factors.

Authors:  Chioma Pedro Emem; Fatiu Arogundade; Abubakr Sanusi; Kayode Adelusola; Friday Wokoma; Adewale Akinsola
Journal:  Nephrol Dial Transplant       Date:  2007-12-08       Impact factor: 5.992

8.  Certification of creatinine in a human serum reference material by GC-MS and LC-MS.

Authors:  Nathan G Dodder; Susan S-C Tai; Lorna T Sniegoski; Nien F Zhang; Michael J Welch
Journal:  Clin Chem       Date:  2007-07-27       Impact factor: 8.327

Review 9.  Antiretroviral nephrotoxicities.

Authors:  Mohamed G Atta; Gilbert Deray; Gregory M Lucas
Journal:  Semin Nephrol       Date:  2008-11       Impact factor: 5.299

10.  Nephrotoxicity of HAART.

Authors:  Robert Kalyesubula; Mark A Perazella
Journal:  AIDS Res Treat       Date:  2011-08-15
View more
  1 in total

1.  Association of urine α1-microglobulin with kidney function decline and mortality in HIV-infected women.

Authors:  Vasantha Jotwani; Rebecca Scherzer; Alison Abraham; Michelle M Estrella; Michael Bennett; Mardge H Cohen; Marek Nowicki; Anjali Sharma; Mary Young; Phyllis C Tien; Joachim H Ix; Mark J Sarnak; Chirag R Parikh; Michael G Shlipak
Journal:  Clin J Am Soc Nephrol       Date:  2014-11-04       Impact factor: 8.237

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.